Results 61 to 70 of about 10,576 (193)

Effectiveness and safety of the ACE inhibitor and diuretic combination in postmenopausal women with arterial hypertension

open access: yesКардиоваскулярная терапия и профилактика, 2011
Aim. To assess effectiveness, tolerability, and safety of combined antihypertensive therapy (AHT) with an ACE inhibitor (perindopril) and thiazide-like diuretic (indapamide) in postmenopausal women with arterial hypertension (AH).
G. G. Semenkova, E. E. Matvienko
doaj   +1 more source

The Heart of the Thymus: A Rare Tale of Nonischemic Cardiomyopathy in the Absence of Myasthenia Gravis

open access: yesClinical Case Reports, Volume 14, Issue 6, June 2026.
ABSTRACT Thymomas are rare epithelial tumors of the anterior mediastinum known for their association with autoimmune and paraneoplastic syndromes, most notably myasthenia gravis (MG). Cardiomyopathy is an exceptionally rare paraneoplastic manifestation.
Manish Barman   +5 more
wiley   +1 more source

Perindopril and a Galectin-3 Inhibitor Improve Ischemic Heart Failure in Rabbits by Reducing Gal-3 Expression and Myocardial Fibrosis

open access: yesFrontiers in Physiology, 2019
Objective: Ventricular remodeling is considered the basis of heart failure and is involved in myocardial fibrosis. This study aimed to assess perindopril and a galectin-3 inhibitor (modified citrus pectin, MCP) for their effects on ventricular remodeling
Sha Li   +4 more
doaj   +1 more source

Salt‐Driven Silk Fibroin Assembly for Solvent‐Free Multienzyme Co‐Immobilization

open access: yesChemCatChem, Volume 18, Issue 12, 26 June 2026.
Salt‐induced silk fibroin assembly enables solvent‐free co‐immobilization of redox enzyme cascades in fully aqueous media without covalent modification. The protein matrix provides high operational stability and modulates cofactor accessibility, enhancing functional coupling within the confined microenvironment.
Juan Cruz Almada   +3 more
wiley   +1 more source

Short-term and long-term cardiovascular actions of different doses of perindopril in the rabbit

open access: yes, 1996
Short-term (one week) and chronic (six week) cardiovascular effects of orally administered perindopril were examined in the rabbit to demonstrate if short-term results can predict chronic outcomes.
Fennessy, P. A.   +4 more
core   +1 more source

Perindopril - a landmark in hypertension and cardiovascular disease management. [PDF]

open access: yes, 2011
Hypertension is a major cardiovascular and cerebrovascular risk factor and is highly prevalent throughout the world, affecting 50% of people over 60 years of age. Angiotensin-converting enzyme (ACE) inhibitors are the gold standard in the treatment of
Milovanovič Jarh, Darja   +2 more
core   +1 more source

Diabetic Peripheral Neuropathy: Molecular Staging, Risk Factors, Therapeutics, and Emerging Trends

open access: yesMed Research, Volume 2, Issue 2, Page 309-342, June 2026.
The heterogeneous landscape of DPN can be unified through a tripartite pathogenic model encompassing progressive stages of metabolic dysregulation, chronic inflammation, and overt neuronal damage. Within this framework, six clinical subtypes were identified, namely, hyperglycemia‐driven, dyslipidemia‐driven, inflammation‐driven, dysvascularity‐driven ...
Xiaofeng Dai, Mingze Tang
wiley   +1 more source

Clinical and pharmaco-economic assessment of ACE inhibitors perindopril and enalapril in coronary heart disease patients after coronary artery bypass graft surgery

open access: yesКардиоваскулярная терапия и профилактика, 2009
Aim. To perform clinical and pharmaco-economic assessment of long-term therapy with ACE inhibitors perindopril and enalapril in coronary heart disease (CHD) patients after coronary artery bypass graft (CABG) surgery.Material and methods. This prospective,
Yu. M. Lopatin, E. P. Dronova
doaj  

Post Hoc Analysis of the CONFIDENCE II, PROTECT I, SHAKE THE HABIT I and SHAKE THE HABIT II Observational Studies in Mild to Moderate Hypertensive Patients Treated with Perindopril and Atorvastatin Concomitantly

open access: yesDrugs in R&D, 2018
Background and Objectives Management of hypertension and dyslipidemia is important when considering cardiovascular disease risk; however, achievement of optimal lipid and blood pressure (BP) targets in clinical practice remains inadequate.
John S. Sampalis   +4 more
doaj   +1 more source

Modulation of advanced glycation endproducts (AGEs) signaling in experimentally induced stroke in mice

open access: yesZagazig Journal of Pharmaceutical Sciences, 2020
Stroke is a leading cause of death and permanent disability in adults worldwide. Advanced glycation endproducts (AGEs) are known to be increased in several chronic diseases and induce inflammation and protein crosslinking. The current study was designed
Amany Yosry   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy